Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CACNA1C gene encodes the alpha-1C subunit of a voltage-dependent L-type calcium channel (CaV1.2). This protein forms the main pore-forming component of the channel complex, which is essential for mediating calcium ion influx into cells upon membrane depolarization. It is crucial for generating electrical signals, regulating muscle contraction, neurotransmitter release, gene expression, and cell-to-cell communication. Dysregulation is associated with cardiac arrhythmias and psychiatric disorders.
L-type calcium channel blocker
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-dependent L-type Calcium Channel Subunit Alpha1C (CaV1.2).